Carbidopa

CAS 28860-95-9 13 current records 8 historicalSmall Molecule

Who holds supplier records for Carbidopa? 13 organisations hold a current record for Carbidopa: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 10 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5), China (4), Switzerland (2), Netherlands (1) and 1 other country (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Carbidopa: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/carbidopa

Reading the evidence

  • 13 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 7 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (13)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Carbidopa. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • TAPI NL BV
    Active DMF 8296, 8656 · latest filing Jul 1990
    NetherlandsCEP
  • Divis Laboratories
    Active DMF 17846 · latest filing Nov 2004
    IndiaCEP Company GMP cert on record
  • FERMION OY
    Active DMF 26416 · latest filing Sept 2012
    FinlandCEP Company GMP cert on record
  • MAITHRI DRUGS PRIVATE LTD
    Active DMF 35521 · latest filing Dec 2020
    IndiaCEP Company GMP cert on record
  • SHANDONG XINHUA PHARMACEUTICAL CO LTD
    Active DMF 27430 · latest filing Jul 2013
    ChinaCEP Company GMP cert on record
  • Zhejiang Chiral Medicine Chemicals Co., Ltd.
    Active DMF 19899 · latest filing Oct 2006
    ChinaCEP
  • Zhejiang Wild Wind Pharmaceutical Co.,Ltd.
    Active DMF 22424 · latest filing Dec 2008
    ChinaCEP
  • ZHEJIANG YONGTAI CHIRAL MEDICINE TECHNOLOGY CO LTD
    Active DMF 37758 · latest filing Nov 2023
    ChinaCEP
  • Bachem SA, Succursale de Vionnaz
    Active DMF 9231 · latest filing Jul 1991
    Switzerland Company GMP cert on record
  • GLOCHEM INDUSTRIES LTD
    Active DMF 25563 · latest filing Dec 2011
    India
  • MSN LIFE SCIENCES PRIVATE LIMITED
    Active DMF 41427 · latest filing Mar 2025
    India Company GMP cert on record
  • Hetero Drugs Limited
    Inactive DMF 37354 · latest filing Aug 2022
    IndiaCEP Company GMP cert on record
  • BACHEM S.A.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    SwitzerlandCEP
Need Carbidopa sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (10)

Certificates of Suitability on the EDQM register for Carbidopa, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 19 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
MAITHRI DRUGS PRIVATE LIMITED BonthapallyIN
CEP 2020-143 - Rev 01
Carbidopa monohydrate
May 2026Inspected Aug 2025
Sweden
FERMION OY EspooFI
CEP 2025-265 - Rev 00
Carbidopa monohydrate, Micronised
Jul 2025Inspected Feb 2026
Finland
TAPI NL B.V. AmsterdamNL
CEP 2001-352 - Rev 09
Carbidopa monohydrate
Jul 2025—
Zhejiang Yongtai Chiral Medicine Technology Co., Ltd. Taizhou CityCN
CEP 2024-034 - Rev 00
Carbidopa monohydrate, Site Yongtai Chiral, Process B, non-micronised
Mar 2024—
HETERO DRUGS LIMITED HyderabadIN
CEP 2022-358 - Rev 00
Carbidopa monohydrate
Sept 2023—
ZHEJIANG CHIRAL MEDICINE CHEMICALS CO., LTD. HangzhouCN
R1-CEP 2007-067 - Rev 06
Carbidopa monohydrate, Micronised, non-micronised
Aug 2023—
SHANDONG XINHUA PHARMACEUTICAL CO., LTD. ZiboCN
R1-CEP 2016-052 - Rev 00
Carbidopa monohydrate
Apr 2022—
DIVI'S LABORATORIES LIMITED HyderabadIN
R1-CEP 2005-057 - Rev 05
Carbidopa monohydrate
Nov 2021—
BACHEM S.A. VionnazCH
R1-CEP 2000-012 - Rev 08
Carbidopa monohydrate
Dec 2019—
ZHEJIANG WILD WIND PHARMACEUTICAL CO., LTD. Geshan TownCN
R1-CEP 2009-073 - Rev 01
Carbidopa monohydrate
Apr 2018—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (8)

Organisations whose Type II DMFs for Carbidopa are no longer active. These show a past filing, not current supply.

Show all 8 historical records
  • India · Inactive DMF 18245 · filed Apr 2005
  • KNOLL AG
    Inactive DMF 11246 · filed Dec 1994
  • Japan · Inactive DMF 9433 · filed Nov 1991
  • ESTEVE QUIMICA SA
    Inactive DMF 9061 · filed Apr 1991
  • Hungary · Inactive DMF 8189 · filed Aug 1989
  • Daito
    United Kingdom · Inactive DMF 8127 · filed Jul 1989
  • AMERICAN CHEMICAL INDUSTRIAL CORP
    Inactive DMF 7361 · filed Feb 1988
  • Japan · Inactive DMF 7063 · filed Jun 1987

Overview

Carbidopa is a medication used in the management of Parkinson's disease, often in combination with levodopa. It acts by inhibiting the enzyme aromatic L-amino acid decarboxylase, thereby preventing the conversion of levodopa into dopamine outside the brain.

Therapeutic areas

NeurologyParkinson's Disease

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Carbidopa?

13 organisations hold an active US FDA Type II Drug Master File or a CEP for Carbidopa: TAPI NL BV (Netherlands), Divis Laboratories (India), FERMION OY (Finland), MAITHRI DRUGS PRIVATE LTD (India), SHANDONG XINHUA PHARMACEUTICAL CO LTD (China), Zhejiang Chiral Medicine Chemicals Co., Ltd. (China), Zhejiang Wild Wind Pharmaceutical Co.,Ltd. (China) and ZHEJIANG YONGTAI CHIRAL MEDICINE TECHNOLOGY CO LTD (China), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Carbidopa Drug Master Files are active?

TAPI NL BV (DMF 8296, 8656), Divis Laboratories (DMF 17846), FERMION OY (DMF 26416), MAITHRI DRUGS PRIVATE LTD (DMF 35521), SHANDONG XINHUA PHARMACEUTICAL CO LTD (DMF 27430), Zhejiang Chiral Medicine Chemicals Co., Ltd. (DMF 19899), Zhejiang Wild Wind Pharmaceutical Co.,Ltd. (DMF 22424) and ZHEJIANG YONGTAI CHIRAL MEDICINE TECHNOLOGY CO LTD (DMF 37758) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Carbidopa records mean?

8 organisations have only inactive Type II DMFs for Carbidopa. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Carbidopa have a European Certificate of Suitability?

Yes. 10 organisations hold a valid CEP for Carbidopa on the EDQM register, including MAITHRI DRUGS PRIVATE LIMITED Bonthapally (IN), FERMION OY Espoo (FI), TAPI NL B.V. Amsterdam (NL), Zhejiang Yongtai Chiral Medicine Technology Co., Ltd. Taizhou City (CN), HETERO DRUGS LIMITED Hyderabad (IN) and ZHEJIANG CHIRAL MEDICINE CHEMICALS CO., LTD. Hangzhou (CN) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Carbidopa supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Carbidopa?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.